OTHER CANCER
Clinical trials for OTHER CANCER explained in plain language.
Never miss a new study
Get alerted when new OTHER CANCER trials appear
Sign up with your email to follow new studies for OTHER CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug shows promise for rare lung complication after transplant
Disease control OngoingThis study tests the drug ruxolitinib for people who developed bronchiolitis obliterans syndrome (BOS), a type of lung scarring, after a stem cell transplant. The goal is to see if the drug can improve lung function or prevent further decline. About 50 participants will take ruxo…
Matched conditions: OTHER CANCER
Phase: PHASE2 • Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated May 19, 2026 11:47 UTC
-
New study: can a fitness coach app boost cancer Survivors' quality of life?
Symptom relief OngoingThis study tests whether live exercise coaching plus a personalized digital app can improve quality of life for cancer survivors. About 146 adults with breast, lung, prostate, colorectal, or other cancers who had treatment in the last year will use the program for 18 months. Rese…
Matched conditions: OTHER CANCER
Phase: NA • Sponsor: Complement Theory Inc. • Aim: Symptom relief
Last updated May 13, 2026 15:58 UTC
-
New study aims to help cancer patients better manage pain
Knowledge-focused OngoingThis study looks at how people with cancer-related pain take their long-acting opioid medications. The goal is to learn what works and what doesn't, so researchers can create a better way to manage cancer pain. About 150 adults who are already prescribed these pain medicines will…
Matched conditions: OTHER CANCER
Phase: NA • Sponsor: Massachusetts General Hospital • Aim: Knowledge-focused
Last updated May 14, 2026 12:05 UTC